Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001589728-17-000004
Filing Date
2017-04-19
Accepted
2017-04-19 19:02:13
Documents
1
Period of Report
2017-03-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7791
  Complete submission text file 0001589728-17-000004.txt   9257
Mailing Address 580 HORNBY STREET FIFTH FLOOR VANCOUVER BC CANADA V6C 2E7 A1
Business Address
LINDSAY ALAN P (Reporting) CIK: 0000942032 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55535 | Film No.: 17771005

Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Issuer) CIK: 0001596062 (see all company filings)

EIN.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
SIC: 2834 Pharmaceutical Preparations